{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:08:48Z","timestamp":1792670928827,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.neuropharm.2014.11.010","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T19:42:36Z","timestamp":1418154156000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Stereochemistry and neuropharmacology of a \u2018bath salt\u2019 cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates"],"prefix":"10.1016","volume":"91","author":[{"given":"Alexandre","family":"Vouga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryah","family":"Haidery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-7562","authenticated-orcid":false,"given":"Hassan K.","family":"Al-Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grizzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen B.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.11.010_bib1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","article-title":"Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys","volume":"22","author":"Banks","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","article-title":"Conditioned place preference using opiate and stimulant drugs: a meta-analysis","volume":"19","author":"Bardo","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2014.11.010_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2014.11.010_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/npp.2013.331","article-title":"Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates","volume":"39","author":"Baumann","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00433569","article-title":"Interactions between motor activity and sterotypy in cocaine-treated rats","volume":"63","author":"Bhattacharyya","year":"1979","journal-title":"Psychopharmacol. Berl."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pbb.2011.05.002","article-title":"Cognitive enhancers for the treatment of ADHD","volume":"99","author":"Bidwell","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2013","journal-title":"Psychopharmacol. Berl."},{"issue":"8","key":"10.1016\/j.neuropharm.2014.11.010_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/dta.155","article-title":"Analyses of second-generation \u2018legal highs\u2019 in the UK: initial findings","volume":"2","author":"Brandt","year":"2010","journal-title":"Drug Test. Anal."},{"issue":"11","key":"10.1016\/j.neuropharm.2014.11.010_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0269881110378370","article-title":"Instability of the ecstasy market and a new kid on the block: mephedrone","volume":"25","author":"Brunt","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cbpc.2008.01.009","article-title":"Neuropharmacology and behavior in planarians: translations to mammals","volume":"147","author":"Buttarelli","year":"2008","journal-title":"Comp. Biochem. Physiol. C. Toxicol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2014.11.010_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.forsciint.2009.12.048","article-title":"Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phtalimidopropiophenone and N-ethylcathinone","volume":"197","author":"Camilleri","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2011.06199.x","article-title":"Designer drugs: a medicinal chemistry perspective","volume":"1248","author":"Carroll","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2011.10.002","article-title":"3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online","volume":"208","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.903450405","article-title":"gamma-Aminobutyric acid in the nervous system of a planarian","volume":"345","author":"Eriksson","year":"1994","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"12","key":"10.1016\/j.neuropharm.2014.11.010_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0091-3057(79)90099-6","article-title":"Metabolism correlates of cocaine-induced stereotypy in rats","volume":"10","author":"Estevez","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2014.11.010_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","article-title":"Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention","volume":"69","author":"Glennon","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2014.11.010_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0091-3057(94)00348-3","article-title":"Methcathione (\u201ccat\u201d): an enantiomeric potency comparison","volume":"50","author":"Glennon","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib20","first-page":"101","article-title":"Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs","volume":"94","author":"Gold","year":"1989","journal-title":"NIDA Res. Monogr."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.drugalcdep.2013.06.014","article-title":"Mephedrone (4-methylmethcathinone), a principal component in psychoactive bath salts, produces behavioral sensitization in rats","volume":"133","author":"Gregg","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.neuropharm.2014.11.010_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/FBP.0000000000000006","article-title":"Mephedrone interactions with cocaine: prior exposure to the \u2018bath salt\u2019 constituent enhances cocaine-induced locomotor activation in rats","volume":"24","author":"Gregg","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib23","article-title":"Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioral and neurochemical effects in rats","author":"Gregg","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.neuropharm.2014.11.010_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present \u2013 a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2014.11.010_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0028-3908(86)90174-7","article-title":"The releasing effect of the isomers of the alkaloid cathinone at central and peripheral catecholamine storage sites","volume":"25","author":"Kalix","year":"1986","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2014.11.010_bib27","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J.\u00a0Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2014.11.010_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2012.04.021","article-title":"Mephedrone (\u2018bath salt\u2019) elicits conditioned place preference and dopamine-sensitive motor activation","volume":"126","author":"Lisek","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","article-title":"Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone","volume":"167","author":"L\u00f3pez-Arnau","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1749-6632.2002.tb04194.x","article-title":"Postnatal cocaine exposure: effects on behavior of rats in forced swim test","volume":"965","author":"Magalh\u00e3es","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2014.11.010_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nic.2007.07.004","article-title":"Imaging the neurochemistry of alcohol and substance abuse","volume":"17","author":"Martinez","year":"2007","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1369-1600.2011.00384.x","article-title":"Mephedrone (4-methylmethcathinone, \u2018meow\u2019): acute behavioural effects and distribution of Fos expression in adolescent rats","volume":"17","author":"Motbey","year":"2012","journal-title":"Addict. Biol."},{"issue":"9","key":"10.1016\/j.neuropharm.2014.11.010_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0269881113490325","article-title":"High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine","volume":"27","author":"Motbey","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2010.03.038","article-title":"Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica","volume":"168","author":"Nishimura","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.07.052","article-title":"In\u00a0vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism","volume":"525","author":"Owaisat","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib39","series-title":"The First Brain: the Neuroscience of Planarians","author":"Pag\u00e1n","year":"2014"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2007.12.008","article-title":"Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones","volume":"89","author":"Pag\u00e1n","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A\u00a0cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuroscience.2013.05.010","article-title":"Planarians require an intact brain to behaviorally react to cocaine, but not to react to nicotine","volume":"246","author":"Pag\u00e1n","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0742-8413(96)00053-9","article-title":"A\u00a0pharmacological study of cocaine activity in planaria","volume":"115","author":"Palladini","year":"1996","journal-title":"Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0742-8413(99)00048-1","article-title":"Opioid-dopamine interaction in planaria: a behavioral study","volume":"124","author":"Passarelli","year":"1999","journal-title":"Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol."},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J.\u00a0Med. Toxicol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib46","series-title":"A\u00a0Model for Drug Action and Abuse","author":"Raffa","year":"2008"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00008877-200311000-00010","article-title":"Disruption of a drug-induced choice behavior by UV light","volume":"14","author":"Raffa","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2007.12.001","article-title":"The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'","volume":"1193","author":"Raffa","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2012.01.019","article-title":"Mephedrone (\u201cbath salt\u201d) pharmacology: insights from invertebrates","volume":"208","author":"Ramoz","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2006.09.047","article-title":"Agmatine blocks morphine-evoked hyperthermia in rats","volume":"1147","author":"Rawls","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.neuroscience.2010.06.041","article-title":"\u03b2-lactamase inhibitors display anti-seizure properties in an invertebrate assay","volume":"169","author":"Rawls","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2011.04.001","article-title":"Nicotine behavioral pharmacology: clues from planarians","volume":"118","author":"Rawls","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2012.06.012","article-title":"Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL\/6J mice: comparison to cocaine","volume":"234","author":"Robinson","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0091-3057(92)90203-R","article-title":"Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze","volume":"43","author":"Rogerio","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2014.11.010_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1037\/a0014103","article-title":"Dual dopamine\/serotonin releasers: potential treatment agents for stimulant addiction","volume":"16","author":"Rothman","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2008.01.012","article-title":"Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians","volume":"583","author":"Rowlands","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2008.04.086","article-title":"Withdrawal-like behavior in planarians is dependent on drug exposure duration","volume":"439","author":"Sacavage","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2014.11.010_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-010-2070-x","article-title":"Mephedrone (4-methylmethcathinone; \u2018meow meow\u2019): chemical, pharmacological and clinical issues","volume":"214","author":"Schifano","year":"2011","journal-title":"Psychopharmacol. Berl."},{"issue":"6","key":"10.1016\/j.neuropharm.2014.11.010_bib60","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in\u00a0vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2014.11.010_bib61","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","article-title":"Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat","volume":"23","author":"Shortall","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib62","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(25)21220-4","article-title":"Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse","volume":"279","author":"Sparago","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib63","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2014.01.002","article-title":"Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in\u00a0vivo","volume":"79","author":"Tallarida","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2014.11.010_bib66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200209000-00008","article-title":"Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies","volume":"13","author":"Volkow","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.11.010_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vascn.2010.08.002","article-title":"Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis","volume":"63","author":"Vyas","year":"2011","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.neuropharm.2014.11.010_bib68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00213-006-0599-5","article-title":"Estimating the relative reinforcing strength of (+\/\u2212)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine","volume":"189","author":"Wang","year":"2007","journal-title":"Psychopharmacol. Berl."},{"issue":"10","key":"10.1016\/j.neuropharm.2014.11.010_bib69","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.16-10-03474.1996","article-title":"Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats","volume":"16","author":"Weiss","year":"1996","journal-title":"J.\u00a0Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2014.11.010_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-8993(98)00905-6","article-title":"Cocaine-induced activation of striatal neurons during focused stereotypy in rats","volume":"810","author":"White","year":"1998","journal-title":"Brain Res."},{"issue":"9752","key":"10.1016\/j.neuropharm.2014.11.010_bib71","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(10)62021-1","article-title":"Mephedrone: still available and twice the price","volume":"376","author":"Winstock","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuropharm.2014.11.010_bib72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","article-title":"Mephedrone, new kid for the chop?","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.neuropharm.2014.11.010_bib73","doi-asserted-by":"crossref","first-page":"e44652","DOI":"10.1371\/journal.pone.0044652","article-title":"Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2014.11.010_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1528-1157.2002.043s2028.x","article-title":"Psychostimulants and epilepsy","volume":"43","author":"Zagnoni","year":"2002","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neuropharm.2014.11.010_bib75","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.neuroscience.2009.06.068","article-title":"Social and physical environment alter cocaine conditioned place preference and dopaminergic markers in adolescent male rats","volume":"163","author":"Zakharova","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.11.010_bib76","first-page":"8","article-title":"Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians","volume":"112\u2013113","author":"Zhang","year":"2013","journal-title":"Physiol Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:10:44Z","timestamp":1747181444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814004262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":72,"alternative-id":["S0028390814004262"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereochemistry and neuropharmacology of a \u2018bath salt\u2019 cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}